The use of a routine blood test to assess and monitor patients with cancer, especially in a longitudinal manner, has long been the holy grail of cancer research.
DONALD J. JOHANN JR, MD, MSC
Advertisement
Articles by DONALD J. JOHANN JR, MD, MSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Patient-Level Data Show Extended OS Advantage With DCVax-L vs External Controls in Glioblastoma
2
Zoldonrasib Combinations Show Compelling Antitumor Activity in RAS G12D–Mutant Metastatic PDAC
3
Hematologists Detail Practice-Shaping Data That Emerged at EHA 2026 (VIDEO)
4
Data Point to Pirtobrutinib-Based Regimens as a New SOC Option for R/R CLL
5